Ocugen Says FDA Declines To Issue EUA For Pediatric Use Of COVAXIN

Drug maker, Ocugen, Inc. (OCGN), said on Friday that the U.S. Food and Drug Administration or FDA, has declined to issue an Emergency Use Authorization or EUA, for the pediatric use of COVAXIN to prevent Covid-19.

However, the company said it "intends to continue working with FDA to evaluate the regulatory pathway for the pediatric use of COVAXIN."

Earlier, Ocugen had intended to get EUA for the vaccine to prevent Covid-19 caused by SARS-CoV-2 in the children of the age group of 2 to 18 years.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Ice Cream maker Ben & Jerry's reportedly filed a lawsuit against parent and British consumer giant Unilever to stop the sale of its Israeli business to a local license-holder Avi Zinger. The company alleged that the decision was made without the approval of its independent board. The judge reportedly denied Ben & Jerry's application for a temporary restraining order against Unilever. J&M Foods is recalling certain Lavender Shortbread Cookies sold through department store chain Target Corp. due to undeclared allergens, the U.S. Food and Drug Administration said. These packages were erroneously packed with Chocolate Chip Cookies and do not disclose the presence of a possible allergen, such as soy or eggs. A multi-state listeria outbreak that has killed one and sickened at least 23 others has been linked to Florida -based Big Olaf Creamery brand ice cream, according to the Centers for Disease Control and Prevention or CDC. The outbreak strain has been reported from 10 states, resulting in 22 hospitalizations. One death has been reported from Illinois.
Follow RTT